DEB, RAHUL, et al. “NEBULIZED BUDESONIDE AS ADD-ON TO STANDARD THERAPY IN CHILDREN AGED 5-14 YEARS WITH ACUTE EXACERBATION OF ASTHMA”. International Journal of Current Pharmaceutical Research, vol. 18, no. 2, Mar. 2026, pp. 138-42, doi:10.22159/ijcpr.2026v18i2.8083.